Patents by Inventor Yong-Min Yang

Yong-Min Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7604955
    Abstract: The present invention concerns the prophylaxis or therapy of immunoglobulin E-mediated disease conditions. The present invention discloses methods for identifying peptides that induce a cytotoxic T-lymphocyte response against immunoglobulin E. The present invention further discloses compositions that are able to elicit in a mammal a cytotoxic T-lymphocyte response to naturally processed and presented immunoglobulin E peptides, and methods for their use.
    Type: Grant
    Filed: August 8, 2002
    Date of Patent: October 20, 2009
    Inventors: Swey-Shen Alex Chen, Yong-Min Yang, Theresa J. Barankiewicz, Zhong Chen
  • Publication number: 20030073142
    Abstract: The present invention concerns the prophylaxis or therapy of immunoglobulin E-mediated disease conditions. The present invention discloses methods for identifying peptides that induce a cytotoxic T-lymphocyte response against immunoglobulin E. The present invention further discloses compositions that are able to elicit in a mammal a cytotoxic T-lymphocyte response to naturally processed and presented immunoglobulin E peptides, and methods for their use.
    Type: Application
    Filed: August 8, 2002
    Publication date: April 17, 2003
    Inventors: Swey-Shen Alex Chen, Yong-Min Yang, Theresa J. Barankiewicz, Zhong Chen
  • Publication number: 20010044108
    Abstract: The present invention comprises method of detecting biomolecules in situ in gel separation medium following electrophoresis that provides sensitivity similar to blotting. This method is applicable to in situ detection of a wide range of biomolecules including proteins and nucleic acids. After electrophoretic separation of a sample in gel separation media comprising a gellable polymeric material other than cross-linked polyacrylamide, the gel is contacted with a solution comprising at least one detectably labeled reagent directed to a biomolecule under conditions suitable for binding of the reagent to the biomolecule. Alternatively, the gel is contacted with a solution comprising at least one non-detectably labeled reagent directed to a biomolecule and a solution comprising at least on detectably labeled reagent directed to a biomolecule. In either case, binding of the detectably labeled reagent is assessed and indicates detection of biomolecules in the gel.
    Type: Application
    Filed: January 26, 2001
    Publication date: November 22, 2001
    Inventors: Lih-Bin Shih, Mark Williams, Patricia M. Vilalta, Yong-Min Yang